These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6831219)

  • 21. Supersensitivity to intrathecal 5-hydroxytryptamine, but not noradrenaline, following depletion of spinal 5-hydroxytryptamine by 5,7-dihydroxytryptamine administered into various sites.
    Sawynok J; Reid A
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jul; 342(1):1-8. PubMed ID: 2402297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional central serotonin-2 receptor binding and phosphoinositide turnover in rats with 5,7-dihydroxytryptamine lesions.
    Butler PD; Pranzatelli MR; Barkai AI
    Brain Res Bull; 1990 Jan; 24(1):125-9. PubMed ID: 2155684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic ACTH treatment: influence on 5-HT2 receptors and behavioral supersensitivity induced by 5,7-dihydroxytryptamine lesions.
    Pranzatelli MR; Eng B
    Peptides; 1989; 10(1):5-8. PubMed ID: 2546129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early postnatal administration of 5,7-DHT: effects on serotonergic neurons and terminals.
    Towle AC; Breese GR; Mueller RA; Coyle S; Lauder JM
    Brain Res; 1984 Sep; 310(1):67-75. PubMed ID: 6383521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
    Lorens SA; Hata N; Cabrera T; Hamilton ME
    NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
    [No Abstract]   [Full Text] [Related]  

  • 26. Regulation of [3H]imipramine binding sites in rat brain regions: effect of neonatal 5,7-dihydroxytryptamine treatment.
    Hrdina PD; Pappas BA; Bialik RJ; Ryan CL
    Eur J Pharmacol; 1982 Sep; 83(3-4):343-4. PubMed ID: 7173315
    [No Abstract]   [Full Text] [Related]  

  • 27. Further studies of serotonergic activity in the regulation of the cold stimulated thyrotropin secretion in male rats.
    Männistö PT; Tuominen RK
    Pharmacol Toxicol; 1988 Aug; 63(2):65-9. PubMed ID: 3186622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of footshock-induced analgesia by spinal 5,7-dihydroxytryptamine lesions.
    Hutson PH; Tricklebank MD; Curzon G
    Brain Res; 1982 Apr; 237(2):367-72. PubMed ID: 7083000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations.
    Pranzatelli MR; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracisternal 5,7-dihydroxytryptamine lesions in neonatal and adult rats: comparison of response to 5-hydroxytryptophan.
    Pranzatelli MR; Dollison AM; Hlibczuk V
    Dev Neurosci; 1989; 11(3):205-11. PubMed ID: 2788568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Selective lesions of serotonergic raphe neurons produced by 5,7-dihydroxytryptamine: effects on interspecific aggressive behavior in the rat].
    Vergnes M; Penot C; Kempf E; Mack G
    Brain Res; 1977 Sep; 133(1):167-71. PubMed ID: 561640
    [No Abstract]   [Full Text] [Related]  

  • 32. 5,7-dihydroxytryptamine-induced mouse killing and behavioral reversal with ventricular administration of serotonin in rats.
    Applegate CD
    Behav Neural Biol; 1980 Oct; 30(2):178-90. PubMed ID: 7192550
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
    Fischette CT; Nock B; Renner K
    Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in the neurocytotoxicity of 5,7-dihydroxytryptamine by pharmacologic agents in adult and developing rats.
    Breese GR; Mueller RA
    Ann N Y Acad Sci; 1978 Jun; 305():160-74. PubMed ID: 280248
    [No Abstract]   [Full Text] [Related]  

  • 35. 5,7-Dihydroxytryptamine as a tool to study the functional role of central 5-hydroxytryptamine neurons.
    Fuxe K; Ogren SO; Agnati LF; Jonsson G; Gustafsson JA
    Ann N Y Acad Sci; 1978 Jun; 305():346-69. PubMed ID: 280251
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of intracerebral injections of 5,7-dihydroxytryptamine and 6-hydroxydopamine on the serotonin-immunoreactive cell bodies and fibers in the adult rat hypothalamus.
    Frankfurt M; Azmitia E
    Brain Res; 1983 Feb; 261(1):91-9. PubMed ID: 6404500
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyrotropin releasing hormone but not histidyl-proline diketopiperazine is depleted from rat spinal cord following 5,7-dihydroxytryptamine treatment.
    Lechan RM; Jackson IM
    Brain Res; 1985 Feb; 326(1):152-5. PubMed ID: 3918765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral evidence for denervation supersensitivity after destruction of central serotonergic nerve terminals.
    Trulson ME; Jacobs BL
    Ann N Y Acad Sci; 1978 Jun; 305():497-509. PubMed ID: 309301
    [No Abstract]   [Full Text] [Related]  

  • 39. Supersensitivity to the respiratory stimulatory effect of TRH in 5,7-dihydroxytryptamine-treated rats.
    Mueller RA; Towle AC; Breese GR
    Brain Res; 1984 Apr; 298(2):370-3. PubMed ID: 6426700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
    McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
    Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.